ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney/pancreas transplantation"

  • 2022 American Transplant Congress

    Portal-Endocrine and Gastric-Exocrine Drainage Technique in Pancreatic Transplantation

    H. Shokouh-Amiri1, M. S. Naseer2, R. McMillan1, D. Aultman1, S. Tandukar1, N. Singh1, G. B. Zibari1

    1John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA, 2Transplant, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA

    *Purpose: Diagnosis of rejection has continued to be problematic in pancreas transplantation (PT). In 2007, we innovated a new surgical technique for PT, portal-endocrine and…
  • 2022 American Transplant Congress

    Extended Duration of Rabbit Antithymocyte Globulin (rATG) Induction in Kidney and Kidney/Pancreas Transplant Recipients

    D. Majmundar, A. Di Carlo, A. Diamond

    Temple University Hospital, Philadelphia, PA

    *Purpose: Many transplant centers have endorsed an expanded duration of rabbit antithymocyte globulin (rATG) in the outpatient setting through peripheral administration to help minimize cost.…
  • 2022 American Transplant Congress

    Temporary Donor Splenic Transplant (Splenopheresis) in Simultaneous Kidney Transplant Provides a Safe Immunologic Window in Sensitized Patients

    P. Di Cocco1, S. Gaitonde2, M. Spaggiari3, A. M. Fratti3, S. Akshelyan3, A. Jorge1, E. Benedetti3, I. Tzvetanov3

    1University of Illinios at Chicago, Chicago, IL, 2Department of Pathology, University of Illinois at Chicago, Chicago, IL, 3University of Illinois at Chicago, Chicago, IL

    *Purpose: Deceased donor solid organ transplant in sensitized recipients with donor specific antibodies (DSA) and positive flow cytometry cross matches (FXM) are challenging due to…
  • 2022 American Transplant Congress

    Tuberculosis (TB) Treatment without Rifampin in Kidney (K) and Kidney-Pancreas (KP) Transplantation (Tx)

    M. V. Radisic1, N. Pujato1, P. M. Bravo1, R. Del Grosso2, M. Hunter2, S. Beltramino3, L. Cornet1, R. Livia Franzini4, A. C. Dotta4, L. Leon4, J. Walther4, P. Uva5, G. Werber3, M. C. Rial4

    1Infectious Diseases, ITAC (Instituto de Trasplante y Alta Complejidad), Ciudad Autonoma de Buenos Aires, Argentina, 2Internal Medicine, ITAC (Instituto de Trasplante y Alta Complejidad), Ciudad Autonoma de Buenos Aires, Argentina, 3Critical Care, ITAC (Instituto de Trasplante y Alta Complejidad), Ciudad Autonoma de Buenos Aires, Argentina, 4Kidney Transplantation, ITAC (Instituto de Trasplante y Alta Complejidad), Ciudad Autonoma de Buenos Aires, Argentina, 5Kidney Pancreas Transplantation, ITAC (Instituto de Trasplante y Alta Complejidad), Ciudad Autonoma de Buenos Aires, Argentina

    *Purpose: TB is a diagnostic and therapeutic challenge in K/KP Tx. Pharmacokinetic interaction between rifampin (RFP) and mTOR /calcineurin inhibitors (CNI) led to use of…
  • 2022 American Transplant Congress

    Favorable Outcomes in Older Recipients Receiving Simultaneous Kidney Pancreas Transplantation

    P. Budhiraja1, H. Me1, J. Ninan2, S. Reddy2, s. S. Misra1, R. Heilman1, H. Khamash1, K. Reddy1, C. Jadloweic1, N. Katariya1, H. Chakkera1

    1Mayo Clinic, Phoenix, AZ, 2Mayo Clinic, Rochester, MN

    *Purpose: Improved therapeutic advances in diabetes mellitus care have resulted in a higher number of older diabetics on dialysis. The majority of centers use an…
  • 2022 American Transplant Congress

    Progression of Peripheral Vascular Disease After Kidney/Pancreas Transplantation

    R. J. Knight, E. A. Graviss, D. T. Nguyen, Y. Ye, S. G. Yi, C. S. Bavare, A. R. Sadhu, H. Podder, M. Hobeika, R. McMillan, A. O. Gaber

    Houston Methodist Hospital, Houston, TX

    *Purpose: It is unclear whether kidney/pancreas (KP) transplantation will prevent the progression of peripheral vascular disease in patients with IDDM and ESRD. We sought to…
  • 2022 American Transplant Congress

    Longitudinal Monitoring of Simultaneous Pancreas and Kidney Transplant and Pancreas After Kidney Recipients Using Donor-Derived Cell-Free DNA

    N. M. Ali1, J. Miles2, Z. Stewart3

    1Transplant Institute, NYU Langone Health, New York, NY, 2CareDx, Brisbane, NY, 3Transplant Institute, NYU Langone Health, New York, NM

    *Purpose: The utility of dd-cfDNA in patients undergoing pancreas transplantation has not been well studied. Pancreatic rejection remains a major clinical concern. Early identification of…
  • 2022 American Transplant Congress

    Recipient and Grafts Outcomes in Simultaneous Kidney and Pancreas Transplantation with Steroid Avoidance in the United States

    A. Cerise1, A. Dinesh2, V. Humphreville2, S. Jackson3, R. Kandaswamy2, S. Riad4

    1Surgery, University of Minnesota, Minnesota, MN, 2Surgery, University of Minnesota, Minneapolis, MN, 3Analytics, MHealth-Fairview, Minneapolis, MN, 4Medicine, University of Minnesota, Eden Prairie, MN

    *Purpose: Steroid avoidance in kidney transplantation has been proven non-inferior. Data on steroid avoidance in simultaneous pancreas-kidney (SPK) is scant.*Methods: We utilized the Scientific Registry…
  • 2022 American Transplant Congress

    Ultra-Short Duration Prophylaxis for Hepatitis C Donor Positive to Recipient Negative Simultaneous Kidney/Pancreas Transplants

    G. Gupta, I. Yakubu, A. Khan, R. Sterling

    Virginia Commonwealth University, Richmond, VA

    *Purpose: Recent trials have successfully utilized a strategy of hepatitis C virus (HCV) D+ [Donor nucleic acid test (NAT) positive]/R- (Recipient NAT negative) kidney and/or…
  • 2022 American Transplant Congress

    Outcomes of Primary Simultaneous Pancreas-Kidney Transplants by Induction Agent in the United States

    A. Cerise1, T. Shaker1, K. Ramanathan1, S. Jackson2, R. Kandaswamy1, S. Riad3

    1Surgery, University of Minnesota, Minneapolis, MN, 2Analytics, MHealth-Fairview, Minneapolis, MN, 3Medicine, University of Minnesota, Minneapolis, MN

    *Purpose: Induction immunosuppression choice for simultaneous pancreas-kidney (SPK) transplants varies widely in the United States. We examined the association between induction agents and outcomes of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 16
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences